Moreover, children with progressive familial intrahepatic cholestasis due to deficiency of the FXR target BSEP have an increased risk of HCC (Table 1) and cases of cholangiocarcinoma are described in patients with BSEP deficiency [156]. This evidence concerns the gene NR1H4 and hepatocellular carcinoma.